In addition it addresses the FDA’s communications Along with the applicant, the retention of documents that assist the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of the SE report to a completely new applicant and electronic submission in the SE rep